Cytek Biosciences share price logo

Cytek Biosciences

NASDAQ: CTKB

Small Cap

$4.81

+0.15

(+3.22%)

as on

Cytek Biosciences Stock Performance

as on August 24, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.59
    $4.83
    downward going graph

    4.57%

    Downside

    0.42%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.28
    $6.18
    downward going graph

    31.81%

    Downside

    28.48%

    Upside

    downward going graph

Cytek Biosciences share price movements today

Previous Close
$4.66
Open
$4.69
Volume
826.9K
Market Cap
$609.6M
Day's Low - High
$4.59 - $4.83
52 Week Low - High
$3.28 - $6.18

Cytek Biosciences Historical Returns

1 Month Return
+ 1.52 %
3 Month Return
+ 37.74 %
1 Year Return
+ 16.96 %
3 Year Return
-44.82 %
5 Year Return
-78.47 %

Cytek Biosciences Stock Fundamentals & Key Indicators

Check Cytek Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$609.6M

EPS (TTM)

-0.12

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.73%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-39.8M

Revenue (TTM)

206.7M

Profit Margin

-38.98%

Return On Equity TTM

-23.04%

Cytek Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytek Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$609.6M-78.47%NA-38.98%NA
BUY$130.1B26.77%35.2214.43%102.06%
BUY$52.8B-21.88%53.277.98%NA
BUY$116.1B-30.2%24.1565.02%3.15%
BUY$192.5B-11.49%3611.65%222.88000000000002%

Stock Returns calculator for Cytek Biosciences Stock including INR - Dollar returns

The Cytek Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Cytek Biosciences investment value today

Current value as on today

₹1,31,042

Returns

₹31,042

(+31.04%)

Returns from Cytek Biosciences Stock

₹19,950 (+19.95%)

Dollar Impact

₹11,092 (+11.09%)

Analyst Recommendation on Cytek Biosciences Stock

Based on 3 analysts

BUY

33.33%

Buy

66.67%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Cytek Biosciences. Average target price of $5.56

Cytek Biosciences Share Price Target

Get share price movements and forecasts by analysts on Cytek Biosciences.

What analysts predicted

13.49%UPSIDE

Target Price

$5.56

Current Price

$4.81

Analyzed by

3 Analysts

Target

$5.56

Cytek Biosciences target price $5.56, a slight upside of 13.49% compared to current price of $4.81. According to 3 analysts rating.

Indian Investors' Interest in Cytek Biosciences Stock

Search interest for Cytek Biosciences Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

Cytek Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
44
46
51
57
41
45
52
62
44
48
Gross Profit
23
25
29
33
20
23
27
32
21
28
Operating Income
-10
-8
-4
2
-14
-10
-9
-5
-18
-11
EBITDA
-6
-4
3
-2
-8
-3
-4
0
-14
-8
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
2
2
2
2
2
2
3
3
2
2
Income Before Tax
-8
-7
0
10
-11
-6
-7
-4
-17
-11
Income Tax Expense
-2
3
0
0
0
-1
-2
40
1
0
Net Income
-6
-10
0
9
-11
-5
-5
-44
-18
-12
Net Profit Margin
-13.75%
-22.38%
1.83%
16.78%
-27.50%
-12.24%
-10.48%
-70.93%
-42.75%
-25.26%

Cytek Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
57
92
127
164
193
200
201
Gross Profit
28
51
79
100
109
111
104
Operating Income
-17
13
9
-1
-27
-20
-40
EBITDA
-15
15
8
9
-4
4
-17
Interest Expense
0
0
1
2
2
5
0
Depreciation
0
0
1
5
8
10
11
Income Before Tax
-16
14
5
1
-15
-5
-29
Income Tax Expense
0
-4
2
-1
-3
0
36
Net Income
-16
19
3
2
-12
-6
-66
Net Profit Margin
-29.07%
20.91%
2.35%
1.57%
-6.29%
-3.00%
-33.02%

Cytek Biosciences Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
0
9
-11
-5
-5
-44
-18
-12
Operating Cash Flow
6
13
1
0
0
-3
0
-2
1
Investing Cash Flow
2
-15
-63
9
-16
18
-1
-27
7
Financing Cash Flow
-1
-12
-3
-11
-2
1
-1
3
0
Change in Cash
8
-15
-63
-3
-19
17
-2
-25
8

Cytek Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
19
3
2
-12
-6
-66
Operating Cash Flow
15
4
-12
5
25
-4
Investing Cash Flow
-1
-20
-55
-93
-82
10
Financing Cash Flow
122
213
5
-41
-15
-13
Change in Cash
135
198
-65
-131
-68
-7

Mutual Funds that own Cytek Biosciences Stock

Check out the Mutual Funds with significant holdings in Cytek Biosciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.570406%
4640930
DFA INVESTMENT DIMENSIONS GROUP INC
1.028013%
1336245
Fidelity Salem Street Trust
1.019898%
1325697
Fidelity Concord Street Trust
0.858454%
1115847
Brown Capital Management Mutual Funds
0.815116%
1059515

Global Institutional Holdings in Cytek Biosciences

Funds
Holdings
Vanguard
4.59%
iShares
4.17%
Chuck Royce
1.26%
Dimensional
0.89%
Schwab
0.45%

Insights on Cytek Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CTKB has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -44.07M → -12.15M (in $), with an average increase of 94.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CTKB stock has moved up by 20.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 44.13M → 48.13M (in $), with an average increase of 8.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Stryker Corporation has given 19.7% return, outperforming this stock by 56.2%

About Cytek Biosciences

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
OrganisationCytek Biosciences
Headquarters47215 Lakeview Blvd, Fremont, CA, United States, 94538-6407
IndustryMedical Devices
CEODr. Wenbin Jiang Ph.D.
E-voting on sharesClick here to vote

Key Management of Cytek Biosciences

Name

Title

Mr. Patrik Sebastian Jeanmonod

Head of Corporate Development Analytics

Dr. Wenbin Jiang Ph.D.

President, CEO & Chairman of the Board

Mr. William D. McCombe

Chief Financial Officer

Dr. Ming Yan Ph.D.

CTO & Director

Mr. Paul D. Goodson

Head of Investor Relations

Mr. Ilan B. Feuchtwang

Chief Legal Officer

FAQs

What is Cytek Biosciences share price today?

Cytek Biosciences share price today is $4.81 as on at the close of the market. Cytek Biosciences share today touched a day high of $4.83 and a low of $4.59.

What is the 52 week high and 52 week low for Cytek Biosciences share?

Cytek Biosciences share touched a 52 week high of $6.18 on and a 52 week low of $3.28 on . Cytek Biosciences stock price today i.e. is closed at $4.81,which is 22.17% down from its 52 week high and 46.65% up from its 52 week low.

What is Cytek Biosciences's market capitalisation today?

Cytek Biosciences market capitalisation is $0.00T as on .

How to invest in Cytek Biosciences Stock (CTKB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cytek Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cytek Biosciences Shares that will get you 0.3119 shares as per Cytek Biosciences share price of $4.81 per share as on August 24, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cytek Biosciences Stock (CTKB) from India?

Indian investors can start investing in Cytek Biosciences (CTKB) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Cytek Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Cytek Biosciences share’s latest price of $4.81 as on August 24, 2026 at 8:46 am IST, you will get 2.0790 shares of Cytek Biosciences. Learn more about fractional shares .

What are the returns that Cytek Biosciences has given to Indian investors in the last 5 years?

Cytek Biosciences stock has given -78.47% share price returns and 29.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?